# A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

> **NCT05857644** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 28 (actual)

## Conditions studied

- Liver Diseases
- Hepatic Impairment

## Interventions

- **DRUG:** PF-07923568

## Key facts

- **NCT ID:** NCT05857644
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-07
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-02-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857644, "A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05857644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*